These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11142053)

  • 1. Technology assessment and the sociopolitics of health technologies.
    Lehoux P; Blume S
    J Health Polit Policy Law; 2000 Dec; 25(6):1083-120. PubMed ID: 11142053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'The problem is small enough, the problem is big enough': a qualitative study of health technology assessment and public policy on drug funding decisions for children.
    Denburg AE; Giacomini M; Ungar WJ; Abelson J
    Int J Equity Health; 2020 Mar; 19(1):45. PubMed ID: 32228588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Social Science Literature on Health Technology Assessment: A Narrative Review.
    Löblová O; Trayanov T; Csanádi M; Ozierański P
    Value Health; 2020 Jan; 23(1):3-9. PubMed ID: 31952670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health technology assessment in four countries: response from political science.
    Chinitz D
    Int J Technol Assess Health Care; 2004; 20(1):55-60. PubMed ID: 15176177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment (HTA): ethical aspects.
    Sacchini D; Virdis A; Refolo P; Pennacchini M; de Paula IC
    Med Health Care Philos; 2009 Nov; 12(4):453-7. PubMed ID: 19507050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care policy: qualitative evidence and health technology assessment.
    Leys M
    Health Policy; 2003 Sep; 65(3):217-26. PubMed ID: 12941490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradigms in operation: explaining pharmaceutical benefit assessment outcomes in England and Germany.
    Kieslich K
    Health Econ Policy Law; 2020 Jul; 15(3):370-385. PubMed ID: 30975237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of health technology assessment.
    Banta D
    Health Policy; 2003 Feb; 63(2):121-32. PubMed ID: 12543525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.
    Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical analysis to improve decision-making on health technologies.
    Saarni SI; Hofmann B; Lampe K; Lühmann D; Mäkelä M; Velasco-Garrido M; Autti-Rämö I
    Bull World Health Organ; 2008 Aug; 86(8):617-23. PubMed ID: 18797620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the integration of social and ethical issues in health technology assessment.
    Lehoux P; Williams-Jones B
    Int J Technol Assess Health Care; 2007; 23(1):9-16. PubMed ID: 17234011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HEALTH TECHNOLOGY ASSESSMENT, DELIBERATIVE PROCESS, AND ETHICALLY CONTESTED ISSUES.
    Daniels N; van der Wilt GJ
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):10-5. PubMed ID: 27472157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we reliably benchmark health technology assessment organizations?
    Drummond M; Neumann P; Jönsson B; Luce B; Schwartz JS; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2012 Apr; 28(2):159-65. PubMed ID: 22559758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported Challenges in Health Technology Assessment of Complex Health Technologies.
    Hogervorst MA; Vreman RA; Mantel-Teeuwisse AK; Goettsch WG
    Value Health; 2022 Jun; 25(6):992-1001. PubMed ID: 35667787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary.
    Swami S; Srivastava T
    Value Health; 2020 Jan; 23(1):39-42. PubMed ID: 31952672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technology assessment: a sociological commentary on reflexive innovation.
    Webster A
    Int J Technol Assess Health Care; 2004; 20(1):61-6. PubMed ID: 15176178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the scope of health technology assessment and types of health economic evaluation.
    Tanvejsilp P; Ngorsuraches S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S10-6. PubMed ID: 24964694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.